Bruker Corporation (BRKR)

Market Cap	6.55B
Revenue (ttm)	3.45B
Net Income (ttm)	79.60M
Shares Out	151.53M
EPS (ttm)	0.52
PE Ratio	82.32
Forward PE	17.16
Dividend	$0.20 (0.46%)
Ex-Dividend Date	Jun 16, 2025

Volume	3,061,218
Open	43.37
Previous Close	43.79
Day's Range	42.39 - 43.62
52-Week Range	34.10 - 72.94
Beta	1.18
Analysts	Buy
Price Target	54.50 (+26.01%)
Earnings Date	Aug 5, 2025

About BRKR

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. It offers magnetic resonance spectroscop, preclinical imaging, biopharma and applied, services and lifecycle support, integrated data solution, and automation; life science...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Aug 4, 2000
• Employees: 11,396
• Stock Exchange: NASDAQ
• Ticker Symbol: BRKR
• Website: https://www.bruker.com

Financial Performance

In 2024, Bruker's revenue was $3.37 billion, an increase of 13.56% compared to the previous year's $2.96 billion. Earnings were $113.10 million, a decrease of -73.53%.

Analyst Summary

According to 12 analysts, the average rating for BRKR stock is "Buy." The 12-month stock price target is $54.5, which is an increase of 26.01% from the latest price.

Price Target

$54.5

(26.01% upside)

Analyst Consensus: Buy